These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Vioxx fallout. Palmer K Minn Med; 2005 Mar; 88(3):26-30. PubMed ID: 15852592 [No Abstract] [Full Text] [Related]
6. Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx. Moynihan R BMJ; 2009 Apr; 338():b1432. PubMed ID: 19349350 [No Abstract] [Full Text] [Related]
7. Bringing the FDA's Information to Market. Woloshin S; Schwartz LM Arch Intern Med; 2009 Nov; 169(21):1985-7. PubMed ID: 19933960 [No Abstract] [Full Text] [Related]
11. [Rofecoxib increases myocardial infarction risk in seniors]. Wasielewski S Med Monatsschr Pharm; 2005 Nov; 28(11):416-7. PubMed ID: 16309032 [No Abstract] [Full Text] [Related]
12. A message from the Vioxx case. Baldwin HJ; Droege M; Daniel KL Am J Health Syst Pharm; 2006 Mar; 63(6):503. PubMed ID: 16522877 [No Abstract] [Full Text] [Related]
13. Evaluating drug effects in the post-Vioxx world: there must be a better way. Avorn J Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873 [No Abstract] [Full Text] [Related]
14. Merck cleared in personal injury case against Vioxx. Mayor S BMJ; 2005 Nov; 331(7525):1101. PubMed ID: 16282390 [No Abstract] [Full Text] [Related]
16. Don't blame it all on the bogey. Day M BMJ; 2007 Jun; 334(7606):1250-1. PubMed ID: 17569929 [TBL] [Abstract][Full Text] [Related]
17. Vioxx doctors wooed by Merck are now its foes. Tesoriero HW Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911 [No Abstract] [Full Text] [Related]
18. What have we learnt from Vioxx? Krumholz HM; Ross JS; Presler AH; Egilman DS BMJ; 2007 Jan; 334(7585):120-3. PubMed ID: 17235089 [TBL] [Abstract][Full Text] [Related]
19. The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry. Cahana A; Mauron A J Anesth; 2006; 20(4):348-51. PubMed ID: 17072707 [No Abstract] [Full Text] [Related]
20. NEJM stands by its criticism of Vioxx study. Tanne JH BMJ; 2006 Mar; 332(7540):505. PubMed ID: 16513694 [No Abstract] [Full Text] [Related] [Next] [New Search]